47415 TABLES RELATED TO GRANT APPROVALS QUARTERLYREPORTTOTHEADVISORYBOARD For the Period October 1st through December 31st, 2008 1. Summary 2. Grant Approvals 3. Grant Disbursements 4. Donor Contributions 5. Closing Observations Annex 1 ­ Tables Relating to Grant Approvals Annex 2 ­ Charts Relating to Grant Disbursements Annex 3 ­ Regional Priority-1 Requirements Annex 4 ­ Regional Priority-2 Requirements Annex 5 ­ Proposed TOR for Mid-Term Evaluation Scenes at the Viral Isolation Unit of the National Laboratory for Veterinary Quality Control on Poultry Production [Published with permission from the NLQP of the Egyptian Ministry of Agriculture and Land Reclamation, Cairo] 1 1. Summary This Report focuses on the financial status of Facility operations as of December 31, 20081. Highlights of this Report include: 41 grants have been approved valued at $82.6 million, reflecting an increase of one $1.2 million grant (Bhutan2) over the endSeptember figure; a grant submission (Morocco) is still undergoing internal review. (see Tables 1, 2 and 3 of Annex 1) Four approved grants await signature; apart from Bhutan2, the remaining three were all approved during the First Quarter of FY09. The Africa region remains grossly underfunded ($26.1 million) while a surplus of resources is available to the East Asia and South Asia regions ($24.5 million). The grant pipeline remains largely unchanged for the other regions. Total disbursements rose to $17.7 million, or 21.4% of total grant approvals. This compares with $14.2 million for the previous Quarter, or about 17% of total grant approvals. ( see Charts 1, 2 and 3 of Annex 2) Three rapid assessment grants in Africa were closed under the multidonor window, and the unused balance of $6,150 was returned to the Facility. Estimated donor pledges rose slightly to $126.4 million equivalent due to a small exchange rate movement, while paidin contributions remained at $107.6 million. 2. Grant Approvals The static growth in grant approvals underscores the continuing mismatch between supply and demand, particularly with respect to the Africa, East Asia and South Asia regions. Thus far, $6.7 million in grants have been approved for Africa, but the region's priority 1 pipeline (Annex 3) reflects an additional demand for $28.8 million, while Priority 2 demand (Annex 4) adds $3.5 million to this total. One gains a broader perspective from the ALive Partnership's INAP Program, which fosters the development and endorsements of INAPs by governments in SubSaharan Africa. The available 22 INAPs (final or final draft versions) to date show an average cost of $13 million per country over the immediate and short term (04 years). Using this average to project the need for 47 SubSaharan countries, the total need becomes $611million, which is consistent with the figure ($590 million) presented in Bamako at the International Ministerial Conference on Avian Influenza in December 2006. Conversely, the East and South Asia regions have a combined demand that is $24.5 million less than available resources, a magnitude that nearly equals the deficit for Africa. Another change worth noting is an increase in the requirements for the Middle East and North Africa region, from $16.1 million to $18.7 million, which is based on updated information for both Jordan and Syria, obtained during a recent mission to those countries. Table 1 summarizes the regionby region demand against the Facility's available resources. Despite a slight drop in the total pipeline requirements and a slight increase in the total resources available, the net deficit grew from $32.0 to $34.7 million since the last report. 1 The focus of this report is limited to the financial status of the AHI Facility because the previous and next Quarterly Reports include more substantive analyses of implementation progress. 2 TABLE 1 AHI FACILITY GRANTS AND AVAILABLE FUNDS BY REGION [ As of December 31, 2008 ] Approved and AHIF Resources Resources Less Regions Priority Levels Pipeline Grant Available to Date Requirements Requirements Africa --Priority 1 $ 35.5 million $ 12.9 million ($22.6 million) --Priority 2 $ 3.5 million Nil ($3.5 million) Europe & Central Asia $ 12.2 million $ 13.9 million $1.7 million** Latin America & Caribbean --Priority 1 $ 6.5 million $ 2.8 million ($3.7 million) --Priority 2 $ 2.5 million Nil ($2.5 million) Middle East & North Africa $ 18.7 million $ 16.3 million ($2.4 million) South Asia --Priority 1 $ 13.9 million $ 13.9 million Nil --Priority 2 $ 1.0 million $ 23.5 million $22.5 million** East Asia & Pacific $ 35.0 million $ 37.0 million $2.0 million** TOTALS & (NET DEFICIT) $ 128.8 million* $ 120.3 million ($34.7 million) * Includes $82.6 million for 41 grants already approved (Africa, $6.7million; East Asia & Pacific, $35.0 million; Europe & Central Asia, $12.2 million; Latin America & Caribbean, $2.8 million; million; Middle East & North Africa, $15.0 million; and South Asia, $10.9 million) ** Due to regional restrictions, these funds may not be used to meet deficits elsewhere. 3. Grant Disbursements Cumulative disbursements increased by 24.6% over the level of three months ago. This increase compares with the 21.7% realized in the previous Quarter, and the 11% and 15% increases of the two preceding Quarters. Notwithstanding this positive trend, disbursements as a proportion of commitments (the disbursement rate) remained modest. This was analyzed in the last Report and discussed at length at the Fourth Meeting of the Advisory Board in late October 2008. The rationale discussed at that time to extend the closing dates of certain windows still obtains. Moreover, as also mentioned in the previous Report, the average disbursement rate of 21.4% belies the broad range of rates among the 28 disbursing grants. For example, 11 grants have disbursed more than 50%, another 7 grants between 30% and 50%, and 8 more between 10% and 30%. Clearly, the average disbursement rate is being lowered by the 13 grants that are not yet disbursing. Charts 1, 2 and 3 of Annex 2 provide the disbursement information presented in the previous Report, updated to include the current Quarter's results. 4. Donor Contributions The status of donor contributions remained virtually unchanged over the past three months, as illustrated in Table 2. The slight movement in the exchange rate (in favor of the Euro against the dollar) caused an increase in total funds anticipated to be available to the Facility, net of the administration fee, from $120.1 million to $120.3 million equivalent. 3 TABLE 2 DONOR PLEDGES & CONTRIBUTIONS TO DATE [As of December 31, 2008] Country / Amount Received to Percentage Organization Pledged Date (US$)* Received** European Commission 70,930,000 79,369,024 80.9% United Kingdom £ 7,000,000 13,491,450 100.0% Australia AUD 10,500,000 8,488,250 100.0% Russian Federation USD 3,000,000 3,000,000 100.0% China USD 2,000,000 2,000,000 100.0% Korea USD 1,000,000 1,000,000 100.0% Iceland USD 200,000 200,000 100.0% Slovenia 30,000 38,373 100.0% Estonia 21,344 27,645 100.0% Total Contributions Received $107,614,742 85.1% *After conversion to US Dollars and before deduction of administration fees **As computed in the pledging currencies 5. Closing Observations The forthcoming midterm evaluation can be expected to objectively determine the Facility's strengths and weaknesses. It is, in addition, likely to identify issues that require more indepth examination, and suggest midcourse changes that not only would benefit the Facility's current mission, but help determine whether the Facility--as well as the instruments like it--is able to take on a longerterm agenda that could potentially include other diseases and health threats. Annex 5 contains a copy of the draft terms of reference for the midterm evaluation. It is part of a larger grant proposal package currently under review by the Advisory Board. Once an external evaluator has been engaged for this task, it is anticipated that a final report would be issued within about three months from the commencement of work. The Administrator welcomes the parallel initiative of the European Commission to evaluate the activities supported by the East and South Asia windows of the Facility, and looks forward to ensuring, to the extent possible without compromising independence and objectivity, that there is mutual support and coordination between the teams involved with the two evaluation efforts. After 30 months of operation, the essential features of the Facility are wellestablished. Judging the degree of success achieved thus far depends upon one's priorities. Facility stakeholders, whether recipient, donor, technical partner or cofinancing agency, will each weigh a particular success factor differently, even though all can be assumed to share the same overarching goals. Both of the evaluation efforts, in combination with the judicious extension of closing dates for selected Facility windows--especially where there is a realistic chance of successful results-- can produce lessons and experiences that will inform responses to future disease threats. 4 Annex 1 TABLES RELATED TO GRANT APPROVALS TABLE 1 CHRONOLOGICAL LIST OF FACILITY GRANTS APPROVED OR UNDER REVIEW In US$ Millions, As of December 31, 2998 European Commission AHI Facility Envelope East & East & Central Eastern Mediterranean Multi Donor TOTAL South Asia South Asia Asia Europe Littoral (TF070515) FACILITY (TF070533) (TF070934) (TF070540) (TF070541) (TF070542) Expected Funds Available* 35.7 32.4 5.9 6.4 13.0 26.8 120.3 Approved Proposals: Lao PDR 1 (2.0) (2.0) Georgia (1.6) (1.6) West Bank and Gaza (3.0) (3.0) Djibouti (2.1) (2.1) Zambia (1.0) (1.0) China (2.7) (2.7) Liberia (0.1) (0.1) Yemen (0.1) (0.1) Sierra Leone (0.1) (0.1) Vietnam (10.0) (10.0) Indonesia (10.0) (10.0) Afghanistan (5.0) (5.0) Regional MNA (1.0) (1.0) Regional LCR (0.5) (0.5) Tajikistan (1.5) (1.5) Mauritania (0.0) (0.0) Uganda (0.1) (0.1) Cambodia (2.0) (2.0) Armenia (2.0) (2.0) Moldova (1.0) (1.0) Malawi (1.0) (1.0) Uzbekistan (3.0) (3.0) Mozambique (0.1) (0.1) Egypt (7.1) (7.1) Myanmar (1.3) (1.3) Bangladesh (2.0) (2.0) Bhutan 1 (1.3) (1.3) Lao PDR 2 (2.4) (2.4) Sri Lanka (1.4) (1.4) Cameroon (1.3) (1.3) Turkmenistan (1.1) (0.9) (2.0) Haiti (1.0) (1.0) Congo (1.0) (1.0) Tunisia (0.7) (0.7) Kyrgrz Republic (0.4) (0.8) (1.2) Mongolia (4.7) (4.7) Honduras (0.3) (0.3) Yemen (1.1) (1.1) Dominican Republic (1.0) (1.0) Uganda (2.0) (2.0) Bhutan 2 (1.2) (1.2) Total Approved: (33.7) (5.9) (5.9) (4.6) (11.8) (20.8) (82.6) Submitted for Review: Morocco (0.9) (0.9) Total Submitted for Review: 0.0 0.0 0.0 0.0 (0.9) 0.0 (0.9) Projected Balance Available 2.0 26.6 0.0 1.8 0.4 6.0 36.8 % of Resources Expected to Be 94.5% 18.1% 100.0% 72.2% 97.1% 77.5% 69.4% Approved by midOctober 2008 * Actuals of contributed and pledged amounts (in millions of US dollars equivalent, net of 5% administration fee) 1-1 TABLE 2 Implementation Status for Approved Facility Grants on 12/31/2008 Approval Signing Approved Disbursed Reflow at Project Names Dates Dates Amounts Amounts Closure Afghanistan** 22Dec06 30May07 $5,000,000 $500,000 Armenia** 12Feb07 08Jun07 $2,000,000 $730,875 Bangladesh** 16Jul07 08Oct07 $2,000,000 $259,955 Bhutan1 19Jul07 02Oct07 $1,300,000 $795,026 Bhutan2 09Dec08 Pending $1,200,000 Nil Cambodia** 05Mar07 08May08 $2,000,000 $210,000 Cameroon 18Oct07 26Mar08 $1,270,000 Nil China 18Oct06 16Apr07 $2,650,000 $1,328,888 Congo 27Feb08 02Jul08 $1,000,000 Nil Djibouti 07Sep06 21Oct06 $2,111,236 $1,021,647 Dominican Republic 12Aug08 Pending $1,000,000 Nil Egypt 18Apr07 29Oct07 $7,141,842 $700,000 Georgia** 18Sep06 23Jan07 $1,600,000 $642,614 Haiti 07Feb08 26Mar08 $1,000,000 Nil Honduras 19May08 01Aug08 $300,000 Nil Indonesia 15Dec06 13Jun07 $10,000,000 $1,000,000 Kyrgyz Republic** 14Apr08 11Jul08 $1,150,000 $230,000 Lao PDR 1** 08Aug06 11Dec06 $2,000,000 $650,148 Lao PDR 2** 06Aug07 07Dec07 $2,400,000 $200,000 Liberia* 28Nov06 19Dec06 $94,300 $89,130 $5,170.34 Malawi 16Apr07 31Jul07 $1,000,000 $200,000 Mauritania* 20Feb07 22Mar07 $29,500 $29,500 $0.40 Moldova** 26Mar07 20Jun07 $1,000,000 $545,287 Mongolia 21Apr08 05Jun08 $4,656,463 $500,000 Mozambique* 07Jun07 10Sep07 $98,850 $47,265 Myanmar 16May07 07Mar08 $1,315,353 Nil Regional LCR 22Dec06 22Jun07 $500,000 $179,263 Regional MNA 19Dec06 01Mar07 $976,899 $762,051 Sierra Leone* 29Nov06 20Dec06 $94,300 $84,772 Sri Lanka 15Oct07 26Mar08 $1,433,000 $705,064 Tajikistan** 22Dec06 22Feb07 $1,500,000 $390,067 Turkmenistan 16Nov07 28Feb08 $1,970,000 $200,000 Tunisia 09Apr08 Pending $653,105 Nil Uganda1* 26Feb07 21May07 $94,300 $93,321 $978.91 Uganda2** 10Sep08 10Oct08 $2,000,000 Nil Uzbekistan 02May07 18May07 $2,960,275 $1,093,669 Vietnam 15Dec06 12Apr07 $10,000,000 $1,012,158 West Bank Gaza 22Sep06 03Oct06 $3,000,000 $2,571,420 Yemen1* 05Feb07 10Feb07 $57,260 $53,881 Yemen2 11Aug08 Pending $1,080,100 Nil Zambia 26Sep06 22Dec06 $999,552 $845,133 TOTALS $82,636,335 $17,671,135 $6,150 *Rapid Assessment Grants **Cofinancing Grants 1-2 TABLE 3 RECENT APPROVALS AND SUBMISSIONS - OCTOBER 1 THROUGH DECEMBER 31, 2008 Country Grant Name Status Date Amount Summary Description Bhutan 2 National Influenza Approved 09Dec08 US$1,200,000 Standalone grant to minimize the threat Preparedness and posed by HPAI infection by preventing and Response Project controlling such infections among birds, Phase II especially domestic poultry, and to prepare for, control, and respond to possible human infections, especially a human influenza epidemic and related emergencies. Morocco Avian Influenza Still 17Sep08 US$1,150,000 Stand alone grant to minimize the threat of Preparedness Pending Highly Pathogenic Avian Influenza (HPAI) to Project human and animal health in the country through improved emergency preparedness and response capability. 1-3 Annex 2 CHARTS RELATED TO GRANT DISBURSEMENTS Chart 1 Total Disbursements by End-Quarter 20.0 18.0 AFR 16.0 sn EAP 14.0 ioll ECA 12.0 LCR Mi 10.0 in $ MENA 8.0 SAR 6.0 US 4.0 Total 2.0 FY07 FY07 FY07 FY07 FY08 FY08 FY08 FY08 FY09 FY09 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Chart 2 FY09-Q2 Disbursement Rates by Region 35% 30% 25% 20% 15% 10% 5% 0% AFR EAP ECA LCR MNA SAR Total 2-1 Chart 3 Disbursement Rates for Grants Approved in FY07 and FY08 (End December 2008) 60% Pe 50% D isb 40% FY07 urse rcent of Gra 30% FY08 d nts 20% 10% 0% AFR EAP ECA LCR MENA SAR 2-2 Annex 3 a in ffa kc m irab Se m St Oder zetn lola Contacts me og Ja Sa d es wari Di fire Sousa Sousa eli eli D BDT BDT Ousa BDT Khama Ro BDT BDT BDT BDT Yv BDT BDT Alfre Ch Ch TB anD anD BDT 09 09 teaD 07t 09 08 09 09 09 09 06 09 09 07r 07b 07n 09 09 Jun03 Jun03 Oc 18 Jun03 Feb 27 Jun03 Jun03 Jun03 Jun03 Nov Ap Fe Ju 28 Jun03 Jun03 16 20 07 Jun03 Jun03 Sources tyil Faci ust nei dev nei dev nei dev nei nei dev dev nei dev nei nei Sta pro pro pro pel pro pro pel pro pel AHI enliepiP Pipel Ap Pipel Ap Pipel enliepiP enliepiP enliepiP Ap Pipel Pi Ap Ap Pi Ap Pi Pipel Funding n) t tn 0 0 her io an ou 00 00 00 00 00 ot Gr 000.2 .01 .2701 .01 .01 50.2 000.2 000.2 000.2 490.0 .3001 005.2 .01 300.0 .01 990 0. 005.2 50.2 mill Am US$ from (in F o m Pr ce ur So gnid JSD & D rag t PHR Gran -financingoC Amount Fun 2008 A t an ithw 31,r gnic ID Gr TBD Region nan A Fi ID edit Cr TBD TBD ecembeD rica Bank Proposals Af IBRD en e en en e en t nc nc Facility ep Gran Ty enolA dna en en en en en Alo dna Alo dna Alo dna Alo dna Alo dna enolA dna enolA dna enolA dna en en en e nc en en Alo Alo Alo dna nafioC Alo Alo Alo dna nafioC Alo Alo dna nafioC Alo dna AHI St St St St St St St St St Stand tandS St or tandS Stand St or Stand St or St la os & lo & lo noit & lo l & lo an Pipeline oprP t trn ectj trn ectj even trn ectj trn ectj an and Gr Co oPr yc Co oPr yc Pr Avian l sponse ss sse Avian l Pl e ncy ncy ncy ncy ncy ned Co oPr yc ntrooC & n Influenza n edn me ger ger tiona ger ger ger arpe tiona onsps Co oPr yc AHI Na Influenza n engre Influenza n engre Influenza n t Re & ssen ecj onseps onseps onseps nt Influenza n engre eventio nt Avia e nt Na e Influenza n engre ma Em s ma Em s ma Eme azn onseps Re s Eme azn onseps Na e Re s edra ep Re s Re s Re s ma Em s Pr na Re & lo ma Em s Hu Hu Hu an Eme azn Eme azn Eme azn Pr mess Prepare azn Pr azn Hu mess mess trn Approved nesd nesd Pro lo uefl nesd uefl nesd nesd uefl nesd uefl nesd Hu se uefl nesd uefl se se Co nesd and arepe and arepe and trn In Co d arepe In arepe th gninehtgn Pl icge ueflIn In In As d and In As th gninehtgn re at re Hum & lortn As d th gninehtgn and Avian Pr Avian Pr Avian an Avian Pr Avian Pr St Influenza trS arepe arepe arepe Avian Pr Avian Pr Avian Pr Rapi In naivA arepe Avian Pr Avian idpaR re arepe St Co Rapi St Influenza Avian Pr or dn wor t ust t t t t t Le Bor Sta ntarG ntarG d edi an Cr Gr ntarG tn raG an tna Gr Gr anrG ntarG tnarG antrG t tna edi en Cr Gr Bl itderC itderC edi edi edit Cr Cr Cr ue ue so y noo ar iq iq n er a ari i aina aina aibi untr Co nieB Fa nikr ad Bu Cam Ch ngooC reitrE eani ana ohto Gu Gh Les beiL aireb urita urita m Li Madagasc Malaw M M Mozamb Mozamb Na 3-1 r ff stca me nga nga el i o dd o o asa Sta nt Ony g Ony g ff tsc & a gereb Su h Co DBT Jantz s akna xk hon Ca gna Yve DBT DBT Sta Wang it ex Conta azza Scur Ro Phillips Wilson Odwon Wilson Odwon Al Mw Pi seiu C. ep Sc en anpad ak Th hniB etaD 09n 06c 09n 09n 07b 08p 06p Alan hiyongS Lo Claudia Ho Wang gnoyihS evtS Kw & amhD Ju De Ju Ju Fe Se Se 06 07 07 (Cont'd) 30 20 30 30 26 10 26 te 07r 06c 06g 08r 07y y Da Ma Oct De Au Aug Ap Ma Feb 06 21 16 05 cilit s de de de de 05 18 15 08 Sources Fa IHA tu linee linee linee Sta prov prov prov prov tyliic Pip Ap Pip Pip Ap Ap Ap ) Fa IHA sut edvor edvor edvor edvor edvor edvor edvor edvor Sta App App App App App App App App nt on ant 00 lli Gr .52 490.0 0 00 .01 .003 590.0 000.2 000.1 t tn 1 Funding mi Amou 35.482 )noill ou 000 056 0 .00 000 0 5 40 000 Gran 2. 2. Am 10 2. 2. 4.656 1.31 0.1 35.02 her US$ m ot (in FD o mi $ Pr ceru JS & D rag FD o ma D D D Pr gr PHR PHR PHR HRDP SDFJ from So ding HRP tn ntu Gra Amo US n(i ecr JS & DR Sou 0 3 PH ount 00 000 00 Fun d) iong Grant 00.3 5.0 2. 5.0 1.78 Am 16.783 t ant Funding -financingoC 2008 an g IDA Gr DBT Reci Gr 00 000 31,r with ecembeD (Cont'niogeR ncin IDA 0.000 1 naiF A ID tide Cr nk Ba cifaPdna .06 4. g in nc na itd 000 Fi k IDA Cre 0.2 0.0002 RD IB Africa e e e iasAts Ban RD IB Proposals ant ep one one onl one one one Gr Ty Al dna financoC St or Al A dnatS Al Al Ea ndatS onlA dna St ndatS Al dna St ndatS ep ncea d en d en an an Grant Ty St Alo St Alo ecnanif d en d en an an St Alo St Alo ecnanif Facility also AHI op & lortn tc & lortn finoC Co Co tc tc la Pr tn Gra Pipeline Co azneufl ssen t & noitne man icnegoht Proje yc nzae Hu ed Pr nc onse ce Prev Co Co tc ar Co azneufl Proje y azneufl Proje ntroloC & no opos & lortn ecj & lortn & lortn seno entiv ss Pa ylhg ur Influ na oje AHI Name In na engr ger nzae nzae nzae and l Hi Pre So Grant I e Co oPr ycn m ger HPAI r ne espR & s m Pr n urce and m Eme eprP In na m Eme In na m Resp & by s AH Na Influ na fo aredpe Influ na ectj Influ na ectj ntro nes of lo Hu tio So Hu nzae Co ness Hu ness Hu nzae en ness tal m Eme m Pro m Pro ilding and na edrape Pr ic edrape Contr r and na Assessment d pi Influ na and na edrape Assessment d pi and na edrape Influ n To Hu ess Avi Pr Ra Avi Avi Pr Ra Avi Pr iavA and n edn ar Approved ia ep Bu yticap m Hu ess Hu ess by sla Pr Tot nde and n edn ar and n edn ar Influenza n Pa ia ep ia ep ia fo tropp nzae evrP Influ na Avi & lortn nd or d wo s Av Pr Ca HI Av Pr Av Pr Av Influena Su Ai Seco Co tu tna tna tna tna tide tide itd n it Len Borr Sta Gr Gr Gr Gr Cr Cr Cre or dn w suta tna dit N/A Le Borro St Cre Gr Blend naoL Loa ntarG Cred tiderC eno eno North ais try ht a try odia ne oliag m un lagen Le Le ,na rar rar na Co Se Sie Sie Sud Sou & dana dana mbi un na PDR o marna et Ug Ug Za Co Camb Chi Indo La Mon My Vi 3-2 v u ffa tsc rd esc rd alij irov id ff s oll oll oll St act Carr Carr Carballo s Carballo s Carr Conta Beda ian Br Petr anioD Yatimo n hian Kh Beda nairB Gob lo jo Sta nt eg G. G. Co Ekanayake J. G. atnA bo dnavy Bo Pe alhK anayakekE J. lshodiD aelhci aelhci Aria o Aria o anayakekE J. anayakekE J. M M Indira egiD egiD ndiraI ndiraI Michael ndiraI (Cont'd) teaD 07b 06p 08r 07 06c 07 07y 09 08 08 80 90 90 Fe Se Ap Mar De Nov Ma 12 18 14 26 22 16 02 teaD 09c 09r 06c tyliic De03 Mar13 Ap10 Aug Feb May 12 07 19 Mar13 De 22 Mar13 s edv edv edv edv edv edv edv tyi Sources Fa IHA en en en en Statu pro pro pro pro pro pro pro Facil sut eni el Ap Ap Ap Ap Ap Ap Ap Sta AHI ipP elipiP eli oved oved oved ipP pprA pprA pprA elipiP oved pprA elipiP 0 Funding )no tna tn ou 000 00 0 0 0 069 18. 0 llii Gr 2. 1.6 151. 1.000 1.50 1.97 2. ) Am 12 ant tnuo on 700 500 Gr 0. 0. 1.500 0001. 0001. 003 500 500 500 50 her m $ llii 0. 0. 0. 0. Am 6. ot from US n(i ecru F DR DR DR DR m $ Pro gram PH PH PH PH US F am t 40 (in ecr Pro gr iong So g JSD & DR PH an JSD & D ount in Gr 408.0 00 00 .41 1.0 .5000 Am 3.7 niog Sou PHR ant tnuo Re t Re Gr Am Fund -financingoC 2008 31,r iasAla Gran 00 3.500 .04 000.4 0 005 .005 g aneb Funding ant Gr IDA 16. 557.1 5571. inc IDA it 0 0 with ecembeD entrCdna ed Carib Finan k IDA Cr 25.6 .5003 000.4 13.75 & A Financing k ID tide Cr Ban RD IB Proposals Ban RD rope America IB e e e e Eu tna e dna en dna en e Gr Typ cenani financ financ financ financ St Alo St Alo Latin Facility ofC ant dna dna dna dna Co Co Co Co Gr Typ St Alone St Alone St Alone St Alone ecnanif dna dna dna dna St Alone St Alone St Alone St Alone Co AHI la tce os op ojrP na na lo na sen na t na t tc m m m m m spo ecjo osalp on t Pr t Hu Hu seno Hu ecjo Control ness Pr Hu Pr Pro ecjo and n azneulf tc Proje s Flu ian Pipeline an nes Gr I e edr m epa and lortn and lortn Contr & espR Hu eR & Av ic ness and s and lortn ness and lortn seno and lortn seno ecr ic ant Pr la ic ic In s e Gr me t t t ian Proje lor ed t and AH Na for S Pr azneulf Co azneulf ci Co azneulf ed ed nes urc arperP ci nes edr by s epa Co azneulf arperP ci Co azneulf espR & s Co azneulf espR & s Sou AHI Na ecjo onitanb eventio ed ecjo Pandem ecjo Av nt epar CA Pr Co ecjo So by sla Pandem a Su Pr a Pandem a Pr a Pr a of Pandem a Pr nz epar nz nz nz Pr enicg nz nz Approved In naivA In n In n Pr t nesde nesde Pr u and noi ia ndem ia ndem ecjo In n In n ar In n ar Tot ia ndem ia ep ia ep Influe na edness State edness edness edness edness ar ná ar ar ent ar ar Total Av Pa Av Pa HPAI Pr Av Pa Av Pr Av Pr ra Fl na Influe na tcej Influe na Influe na Patho ylhg Influe na Influe na Avi Pa Avi Avi Pro Avi Avi Hi Avi Avi eprP or w sut eprP eprP eprP evrP rengtheingtS eprP t it d Lend rrooB an sut an A an an itd A n Sta tiderC tiderC it an tna Gr Cred or d Cred Gr Blen anoL Lo Credit Blend Len rrowoB N/ N/ Sta Lo Lo Lo rantG Cre naoL oaL stan an n l a ni gia zy ic as y me or blup natiskji nie Country Ar Ge Kyrg Re Moldova Ta mkruT try lare ná cain ra mi public durn ua úr giona Uzbekist Coun Brazil Fed Brazil Pa Colombia Do Re Haiti Ho Pe Re LCR ugrU 3-3 eic erè a eic eic es es ffa tsca Tré ai ai t Fr s Tré otd ff stca ra dro eyseker St nt ppeili Lu gna Lu gna Lu gna senhou senhou Vilor Vilor Co Ph G. G. S. Ja Ph Cont Ro kfco Ab e re Cr aneJ lliamsi lliamsi Gigno Scot cque ppeili Ron Sta Qam na quzzamanfiaR . n llin Julie W Julie W Hu Tra Co aneJ Gigno n Gigno n Hu Tra Hu Tra aneJ M m Pier Us S.A. Sandra Ro ardnaS inv anc (Cont'd) Ke Terr etaD 06p 07r 09b 08p 06 09 08 06p 07b 08 e 06c 07l 07l 08c 07t Se Ap 07 18 Fe82 Se71 Dec Feb Apr Se Fe 19 15 09 22 05 Aug11 atD De Ju Ju De Oc 22 16 19 09 15 Sources cility Fa I suta en dett en tyi d d d d St AH Approved Approved ipeliP mibuS Approved ipeliP Approved Approved Approved Approved Facil IHA suta St Approve Approve Approve Approve enilepiP d Approve Funding t t 3 ) an 111 2 00 7 6 3 t tn 0 an on 000 00 000 3 .93 her lli Gr 2. 7.14 1.5 0.888 0.97 1.29 0.65 000.3 057 08 0. 1.0 Amoun 18.704 )noill ou Gr .005 2. 3001. 1.2 3. 431. Am 13 ot mi mi $ from US$ n(i ecr DF Pro JS & gram US n(i ecr F am Pro nt JSD & D gr Sou PHRD Region Grant Amou Sou gn PHR ant Gr Amount nding t -financingoC 2008 Fu Fundi rica 31,r Afh Grant A Gran A 00 8.0 ID ID 8.000 ing gn with Nort A nogieRa it ed 000. ecembeD &ts Financ kn ID Credit 00 Asi Financi kn IDA Cr 6.01 16 Ba uth Ba Ea RD .000 So DR IB 0.0001 10 IB Proposals Middle e ant dna e e on dna e on dna e on dna e on dna e on dna e on dna e ec e e e on Gr Typ St Al St Al St Al St Al St Al St Al St Al nanfi dna on dna on ant St Al St Al Gr Typ Co ofinanceC Stand Alone Stand Alone Stand Alone Stand Alone Facility Cofinanc l lortn tc AHI ectj ectj ectj lo lortn oposa Co d & lor nt ci ntr also and s and s m Na a n Co d ojerP l and gninehtgn and Pr an n Co a tcejo Pro s esn nde )SDICE alnoti Pro s Pro s esn esn Co & n re Hum an n Prop ness ednes ednes and lort nzae ness enz Pr (M edta ar I II St n gr ar e ss e ant Contro ed lu ed Pipeline Grant I entiove edra Pa d sse edra edra an n entiove Inte and na entiove Gr I me and epar eprP eprP for e Co r Inf n epar urc AH Name edra AH Na fo ia Pr a Influ na and tcejo nede eprP a Avian l eprP a eprP a Pr a t Phase t Phase t t the g Svi Pr a Sourc Pr So ness ecjo nzae lu ecjo nzae lu ecjo Pr stanc Av ecjo enz Hum Influ nai tcejo and nai Pr notin Prepar enz eprP a enz enz enz inne for na enz by s ed uenzal Pr margo a Inf l Pr Inf l Pr ssiA la Pr l of no uenzal Pr by sl ta eve Flu nai Av Pr Av Pr Av Influ naivA onaig re enz Influ nai Influ nai Influ nai tcejo th Pl sen sen sen sen ng Total To onti enz Influ nai tcejo arpe Pr Inf n enti Sub Influ Av Av Av Pr Stre Ac Influ Av Pr AHI Avia spoeR onait Na spoeR onait Na spoeR hnicceT onait Inf n Na evrP Avia spoeR Approved or d w rro suta it oanL an nt N/A N/A tider tider t it edi Cred Len Bo St ntarG tnarG tnarG t sut nt Gr raG tnar tnar or dn Le Borrow Sta raG edrC Cr n nk y na a Ba yr tas 1C 2C an untr outib tp ccooro alnoi A isi ria st 1G ne 2G ne ant ant st Co Dji Egy Jord M Reg MN Sy Tun We Gaza & m m unt ghani Lanka i Ye Ye Co Af Bangladesh Bhu Bhu Paki Sr 3-4 Annex 4 Regional Priority-2 Requirements December 31, 2008 Africa Region Projected "Priority 2" Need Grant Possible Country Amounts Submission Dates Burundi $2.50 million 30Nov09 Mali $1.00 million 30Nov09 TOTAL $3.50 million Latin America & Caribbean Region Projected "Priority 2" Need Grant Possible Country Amounts Submission Dates Ecuador $0.25 million 31Mar09 El Salvador $0.25 million 30Jun09 Guatemala $0.25 million 31Mar09 Nicaragua $0.50 million 15Sep09 Panama $0.25 million 30Jun09 Paraguay $1.00 million 30Jun09 TOTAL $2.50 million South Asia Region Projected "Priority 2" Need Grant Possible Country Amounts Submission Dates Sri Lanka $1.00 million 15Apr09 TOTAL $1.00 million 4-1 Annex 5 PROPOSED TERMS OF REFERENCE FOR MIDTERM EVALUTION OF THE AVIAN AND HUMAN INFLUENZA FACILITY (AHIF) Introduction The AHIF was created as a result of the International Pledging Conference on Avian and Human Pandemic Influenza in Beijing in 2006 in order to fill the remaining funding gaps to combat the threat of avian influenza, after other funding sources are taken into account. Altogether, $3 billion equivalent was pledged in support of global, regional and country programs in developing countries at this and subsequent ministerial conferences in 20068. To date, AHIF has received combined pledges of $126 million equivalent from nine donors, led by the European Commission (EC). Pledges to AHIF thus account for about 4 percent of the total international assistance pledged to combat avian and human influenza. Accordingly, the AHIF provides grant funding for developing countries in order to help them reduce financing gaps in implementing their integrated national action plans (INAPs). The AHIF has funded fortyone grants in all regions which include a broad variety of activities, some standalone and others closely coordinated with separately funded efforts, including the Bank's own operations, which currently represent an IBRD/IDA commitment of some $317 million. The EC is also in the process of commissioning consultants to undertake a mid term evaluation of the funding it provides to the AHIF for East and South Asia. While the consultant's terms of reference for this evaluation are being finalized, it is expected that the EC evaluation will also pose some of the same questions for the projects visited by their consultants. These two separate and independently supported evaluations will provide the benefit of different perspectives. Reference documents to this TOR2--Annex I (Description of the Facility), Annex II (Visibility Guidelines) and Annex III (Advisory Board Arrangements and Operating Procedures)--are attached below. Objectives of Evaluation The objectives of the evaluation are: 2 Included in grant proposal currently under Advisory Board review, but omitted in this Annex. 5-1 · To review the progress to date of the AHIF; · To assess the achievements todate of the AHIF as a whole, and of selected grants, in the light of the Facilitys objectives; · To evaluate the extent to which the AHIF has succeeded in its key aim: "to assist countries in meeting their financing gaps in their AHI integrated country action plans, when domestic and existing bilateral or multilateral donor resources are unable to fill the gap." · To make recommendations on ways in which the Facility might better achieve its objectives in the future. Approach In performing the evaluation, Consultants will focus on the AHIF grants, including the small "rapid assessment" grants, made to assist the countries to strengthen their INAPs. The approach adopted by the Consultants will respond to the following questions: · To what extent are AHIFsupported activities achieving the Facilitys objectives? Examine the role and function of AHIF within the broader financing framework articulated in Beijing. AHIF has a specific role to play as financing gap filling in INAPs, capable of rapidly redirecting funding in response to changing circumstances and should be assessed with a recognition that it was not always the primary source of funding. · Is there a strong country ownership of AHIF funded projects? · Is there adequate incountry coordination with stakeholders, especially locallybased donor representatives, prior to finalization of grant proposals? Has AHIF helped in promoting greater donorgovernment and donordonor cooperation? Where has AHIF worked well and where it has not? · Where strengths, weaknesses and limitations are identified, the evaluation should provide detailed assessments on the reasons for success/failure and what alternative approaches might have been more effective? In particular, it will be important to contrast the performance of AHIF (within the context of the AHI Global Response) against other possible funding instruments. · What are the factors contributing to slow disbursements and how they can be improved over the next two year? What is the performance of the AHIF portfolio relative to other disaster responses? To nonemergency projects? Is there evidence of improved performance where other mechanisms have been used in preference to AHIF? 5-2 · To what extent are current approaches to incountry donor consultation of AHIF applications, and donor visibility, effective for the donors? For Government in terms of more coordinated development assistance? · To what extent have the donor visibility guidelines (Annex II) been successfully implemented, both by the AHIF Administrator, and by the project teams? · What has been the valueadded of AHIF projects to World Bank operations? In particular have AHIF funded projects filled the financing gaps identified in the INAPs? · Are there ways in which the Facilitys program management, procedures or policies (Annex III) might be changed to enable its objectives to be achieved more costeffectively? · How well are AHIF grant approvals managed within the Bank, and grant implementation supervised by the Bank's project teams? · Within the different kinds of activities that AHIF has supported, are some more effective in meeting AHIF objectives than others? If so, what are the factors that are contributing to this? · Are there specific lessons learned by the program, in terms of technical design, gap filling, preparedness, and surveillance and institutional capacity, which should be more widely disseminated? · Are there any important structural, administrative or procedural changes that could be made to enhance the responsiveness and effectiveness of AHIF in the future? Scope of Services and Enquiry Sources The Consultants will secure all information needed to support their findings, including, but not limited to, the following: · A desk review of the background materials on the AHIF, including Agreements between the AHIF donors and the World Bank, AHIF operating procedures, details of approved grants, and quarterly progress reports to the donors; · Interviews with key AHIF stakeholders, including AHIF Internal Bank Review Committee (IBRC) members, Task Team Leaders, Trust Fund Coordinators, the AHIF Administrator and AHIF Unit staff; · Assessment of stakeholders and country team members comments on AHIF activities (not necessarily through field visits); · Site visits to selected AHIF project locations, to carry out an assessment of AHIF interventions, and to identify the nature and scale of the progress 5-3 made in building the institutional capacity of the intended grant recipient agencies; and · A final presentation of evaluation conclusions to the AHIF Unit staff, the IBRC and relevant operational staff. Time Schedule The evaluation will require six (6) weeks to complete, including the submission of a final report, which period shall cover two key Tasks: Task I Desk Review and Interviews in Washington This phase of the study will involve preparing an overview of the AHIF program and a preliminary assessment of its achievements, based on written documentation and interviews with World Bank staff. During this phase, the Consultants will also review the overall AHIF portfolio, and categorize the different projects financed, as a basis for selection of a representative sample of completed or substantially complete projects for detailed site review in Task II. The Consultants will propose the projects to review to the World Bank at the end of Task I. Task II Site reviews of sampled projects, to determine impact and likelihood of achieving their objectives Task II shall only commence when the Bank Task Manager provides the Consultants written acceptance authorization to proceed with Task II. The written authorization will include the approved list of up to a maximum of three (3) projects (excluding projects in South and SouthEast Asia) to be reviewed. It is expected that Task II would commence within one month of completion of Task I (to allow for the logistics in mobilizing to Task II locations, including alerting Bank offices and concerned stakeholders). After completion of the fieldwork, the Consultants would report to the World Bank on the results and conclusions of their overall study. Reports The Evaluation Team will submit: · A brief initial inception report within one week of starting work; 5-4 · An interim report towards the end of Task I, including proposals for the projects to be studied in detail during Task II; · A draft final report for discussion with the IBRC and other stakeholders, at the conclusion of Task II. The draft final report will include an analysis of AHIF activities to date, including identification of the specific AHI disciplinary areas which the projects examined have addressed; · Following draft final report submission, the Consultants will make a complete presentation of their findings and recommendations during a workshop to be convened in Washington. The workshop will serve as a forum for eliciting comments from attending stakeholders; and · A final report reflecting comments made on the draft final report. These reports will be in full document form (not PowerPoint presentations). They will be provided in electronic format and in ten hard copies. Services and Facilities to be Provided by the Bank The Global Partnership and Trust Fund Operations (PTO) Department in the World Bank will have management responsibility for oversight and supervision of the evaluation, and has appointed a Task Manager, who will handle dayto day implementation of the assignment on behalf of the Bank, as well as serve as lead representative in the Banks relationship with the Consultants. A Review Group will be made available to guide and support the consultant team, and will meet with the team on several occasions, virtually or physically as appropriate. The Review Group will include representatives of PTO, and the IBRC. The Task Manager will provide the secretariat function for this Review Group. The task manager and the AHIF Unit in PTO will provide access to all relevant materials to the Consultants. PTO will provide office space to the consultant team during Task I and as needed. While the Review Group will provide specific comments in a consolidated manner on the Inception, Interim and Draft Final Reports produced by the Consultants, the exact dates of any meetings requested by the Consultants cannot be agreed at the outset of the work due to the difficulty in coordinating with Group members. 5-5